Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial
John D Hainsworth, Gedske Daugaard, Thierry Lesimple, Gerdt Hübner, F Anthony Greco, Michael J Stahl, Christian Meyer Zum Büschenfelde, Djelila Allouache, Nicolas Penel, Poul Knoblauch, Karim S Fizazi
Dive into the research topics of 'Paclitaxel/carboplatin with or without belinostat as empiric first-line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial'. Together they form a unique fingerprint.